{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:04:05Z","timestamp":1792069445837,"version":"4.4.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"vor","delay-in-days":381,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.jacc.2019.01.051","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T15:49:39Z","timestamp":1554738579000},"page":"1769-1778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Effect of Angiotensin II Inhibitors on Gastrointestinal Bleeding in Patients With Left\u00a0Ventricular Assist Devices"],"prefix":"10.1016","volume":"73","author":[{"given":"Maureen P.","family":"Converse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoosh","family":"Sobhanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Taber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A.","family":"Houston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly B.","family":"Meadows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter E.","family":"Uber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2019.01.051_bib1","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics - 2017 update: a report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.01.051_bib2","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.healun.2015.10.003","article-title":"Seventh INTERMACS annual report: 15,000 patients and counting","volume":"34","author":"Kirklin","year":"2015","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2019.01.051_bib3","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMoa0909938","article-title":"Advanced heart failure treated with continuous-flow left ventricular assist device","volume":"361","author":"Slaughter","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.01.051_bib4","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jacc.2009.03.055","article-title":"Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device","volume":"54","author":"Pagani","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.01.051_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/CIRCHEARTFAILURE.111.963991","article-title":"Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy","volume":"5","author":"Park","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2019.01.051_bib6","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1161\/CIRCULATIONAHA.111.040246","article-title":"Bleeding and thrombosis in patients with continuous-flow ventricular assist devices","volume":"125","author":"Eckman","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.01.051_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.healun.2003.10.018","article-title":"GI bleeding from arterio-venous malformations in patients supported by the Jarvik 2000 axial flow left ventricular assist device","volume":"24","author":"Lestou","year":"2005","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2019.01.051_bib8","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1540-8191.2010.01025.x","article-title":"Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD","volume":"25","author":"Stern","year":"2012","journal-title":"J\u00a0Card Surg"},{"key":"10.1016\/j.jacc.2019.01.051_bib9","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jacc.2010.05.016","article-title":"Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation","volume":"56","author":"Uriel","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.01.051_bib10","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.athoracsur.2011.06.081","article-title":"Lessons learned from experience with over 100 consecutive HeartMate II left ventricular assist devices","volume":"92","author":"John","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2019.01.051_bib11","first-page":"849","article-title":"Arteriovenous malformation and gastrointestinal bleeding in patients with Heartmate II left ventricular assist device","volume":"30","author":"Demirozu","year":"2011","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2019.01.051_bib12","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.athoracsur.2012.02.035","article-title":"Incidence and management of gastrointestinal bleeding with continuous flow assist devices","volume":"93","author":"Aggarwal","year":"2012","journal-title":"Ann Thoracic Surg"},{"key":"10.1016\/j.jacc.2019.01.051_bib13","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.jacc.2009.02.048","article-title":"Severely impaired von Willebrand\u2019s factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device","volume":"53","author":"Klovaite","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.01.051_bib14","first-page":"141","article-title":"Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device","volume":"2","author":"Meyer","year":"2014","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2019.01.051_bib15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.14797\/mdcj-11-1-24","article-title":"Gastrointestinal bleeding after continuous-flow left ventricular device implantation: review of pathology and management","volume":"11","author":"Guha","year":"2015","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"10.1016\/j.jacc.2019.01.051_bib16","first-page":"303","article-title":"Gastrointestinal bleeding in recipients of the HeartWare ventricular assist system","volume":"3","author":"Goldstein","year":"2015","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2019.01.051_bib17","first-page":"e002680","article-title":"Relationship between anticoagulation intensity and thrombotic or bleeding outcomes among outpatients with continuous-flow left ventricular assist devices","volume":"9","author":"Nassif","year":"2016","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2019.01.051_bib18","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.gie.2011.12.014","article-title":"Evaluation of GI bleeding after implantation of left ventricular assist device","volume":"75","author":"Kushnir","year":"2012","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jacc.2019.01.051_bib19","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.healun.2013.12.008","article-title":"Safety of discontinuation of anti-coagulation in patients with continuous-flow left ventricular assist devices","volume":"33","author":"Kamdar","year":"2014","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2019.01.051_bib20","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.healun.2015.06.018","article-title":"Safety of reduced anti-thrombotic strategies in HeartMate II patients: a one-year analysis of the US-TRACE study","volume":"34","author":"Katz","year":"2015","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2019.01.051_bib21","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1182\/blood.V122.21.1057.1057","article-title":"Patients with end stage congestive heart failure have decreased high molecular weight von Willebrand factor multimers and higher plasma levels of total TGF-\u03b21: implantation of a\u00a0left ventricular assist devices (LVAD) exacerbates both abnormalities","volume":"122","author":"Ahamed","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2019.01.051_bib22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1055\/s-0029-1240709","article-title":"Effect of pulsatile and nonpulsatile left ventricular assist devices on the renin-angiotensin system in patients with end-stage heart failure","volume":"58","author":"Welp","year":"2010","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2019.01.051_bib23","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1182\/blood-2009-01-199166","article-title":"Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells","volume":"114","author":"Shao","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2019.01.051_bib24","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/jcp.21706","article-title":"Transforming growth factor-beta 1 induces angiogenesis through vascular endothelial growth factor mediated apoptosis","volume":"219","author":"Ferrari","year":"2009","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.jacc.2019.01.051_bib25","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1378\/chest.128.6_suppl.585S","article-title":"Transforming growth factor-beta signal transduction in angiogenesis and vascular disorders","volume":"128","author":"Bertolino","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2019.01.051_bib26","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2337\/diabetes.50.4.867","article-title":"Angiotensin II induces expression of the Tie2 receptor ligand, angiopoietin-2, in bovine retinal endothelial cells","volume":"50","author":"Otani","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.jacc.2019.01.051_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/CIRCULATIONAHA.115.019692","article-title":"Elevated angiopoietin-2 level in patients with continuous-flow left ventricular assist devices leads to altered angiogenesis and is associated with higher nonsurgical bleeding","volume":"134","author":"Tabit","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.01.051_bib28","unstructured":"Dana S, Marasco RA, Sengson S. Outcomes based therapeutic interchange: an ACE inhibitor interchange program. American Society of Consultant Pharmacists, Inc. Available at: http:\/\/www.globalrph.com\/aceinh.html. Accessed October 10, 2016."},{"key":"10.1016\/j.jacc.2019.01.051_bib29","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jtcvs.2009.11.020","article-title":"Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes","volume":"139","author":"Kormos","year":"2010","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2019.01.051_bib30","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A\u00a0proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.jacc.2019.01.051_bib31","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/cc2872","article-title":"Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"8","author":"Bellomo","year":"2004","journal-title":"Crit Care"},{"key":"10.1016\/j.jacc.2019.01.051_bib32","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.healun.2013.07.020","article-title":"Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device","volume":"33","author":"Stulak","year":"2014","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2019.01.051_bib33","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/jocs.12474","article-title":"Ventricular assist devices and increased blood project utilization for cardiac transplantation","volume":"30","author":"Stone","year":"2015","journal-title":"J\u00a0Card Surg"},{"key":"10.1016\/j.jacc.2019.01.051_bib34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jtcvs.2014.09.031","article-title":"Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: Mechanical demolition and enzymatic cleavage","volume":"149","author":"Bartoli","year":"2015","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2019.01.051_bib35","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.amjcard.2015.10.041","article-title":"Risk factors and outcomes of gastrointestinal bleeding in left ventricular assist device recipients","volume":"117","author":"Joy","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2019.01.051_bib36","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/CIRCHEARTFAILURE.112.000206","article-title":"Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II","volume":"6","author":"Wever-Pinzon","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2019.01.051_bib37","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.healun.2015.12.024","article-title":"Longitudinal changes in hemostatic parameters and reduced pulsatility contribute to non-surgical bleeding in patients with centrifugal continuous-flow left ventricular assist devices","volume":"35","author":"Muthiah","year":"2016","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2019.01.051_bib38","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1111\/j.1582-4934.2008.00218.x","article-title":"The somatastatin analogue octreotide inhibits angiogenesis in the earliest, but not in advanced, stages of portal hypertension in rats","volume":"12","author":"Mejias","year":"2008","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.jacc.2019.01.051_bib39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/MAT.0000000000000143","article-title":"Octreotide in the management of recurrent gastrointestinal bleed in patients supported by continuous flow left ventricular assist devices","volume":"61","author":"Loyaga-Redon","year":"2015","journal-title":"ASAIO J"},{"key":"10.1016\/j.jacc.2019.01.051_bib40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/MAT.0000000000000491","article-title":"Tolerability and biological effects of long acting octreotide in patients with continuous flow left ventricular assist devices","volume":"63","author":"Malhotra","year":"2016","journal-title":"ASAIO J"},{"key":"10.1016\/j.jacc.2019.01.051_bib41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.healun.2016.01.694","article-title":"A\u00a0multicenter evaluation of octreotide for ventricular assist device related gastrointestinal bleeding","volume":"35","author":"Smallfield","year":"2016","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2019.01.051_bib42","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/MAT.0000000000000087","article-title":"Treatment of left ventricular assist device-associated arteriovenous malformations with thalidomide","volume":"60","author":"Ray","year":"2014","journal-title":"ASAIO J"},{"key":"10.1016\/j.jacc.2019.01.051_bib43","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.healun.2014.09.013","article-title":"Thalidomide for treatment of gastrointestinal angiodysplasia in patients with left ventricular assist devices: case series and treatment protocol","volume":"34","author":"Draper","year":"2015","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2019.01.051_bib44","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/01.CIR.103.6.789","article-title":"Angiotensin II blockade reverses myocardial fibrosis in transgenic mouse model of human hypertrophic cardiomyopathy","volume":"103","author":"Lim","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.01.051_bib45","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1097\/01.hjh.0000182521.44440.c5","article-title":"Neutralization of transforming growth factor-beta attenuates hypertension and prevents renal injury in uremic rats","volume":"23","author":"Lavoie","year":"2005","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2019.01.051_bib46","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","article-title":"Angiotensin II blockade and aortic-root dilation in Marfan\u2019s syndrome","volume":"358","author":"Brooke","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.01.051_bib47","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1161\/CIRCULATIONAHA.109.883629","article-title":"Transforming growth factor-\u03b2: a biomarker in Marfan syndrome","volume":"120","author":"Braverman","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.01.051_bib48","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1053\/ajkd.2000.19078","article-title":"ACE inhibitors attenuate expression of renal transforming growth factor-beta1 in humans","volume":"36","author":"Shin","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2019.01.051_bib49","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.2337\/dc06-0911","article-title":"Transforming growth factor beta in human diabetic nephropathy: effects of ACE inhibition","volume":"29","author":"Langham","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2019.01.051_bib50","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000072820","article-title":"Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients","volume":"23","author":"el-Agroudy","year":"2003","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jacc.2019.01.051_bib51","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1159\/000069792","article-title":"Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor","volume":"23","author":"Yoshiji","year":"2002","journal-title":"Tumour Biol"},{"key":"10.1016\/j.jacc.2019.01.051_bib52","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.healun.2016.12.016","article-title":"Angiotensin II antagonism is associated with reduced risk for gastrointestinal bleeding to due arteriovenous malformations in patients with left ventricular assist devices","volume":"36","author":"Houston","year":"2016","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2019.01.051_bib53","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/10623320500476559","article-title":"Atorvastatin affects several angiogenic mediators in human endothelial cells","volume":"12","author":"Dulak","year":"2005","journal-title":"Endothelium"},{"key":"10.1016\/j.jacc.2019.01.051_bib54","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2141.2009.08031.x","article-title":"Von Willebrand disease, angiodysplasia and atorvastatin","volume":"149","author":"Alikhan","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jacc.2019.01.051_bib55","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1365-2141.2008.07005.x","article-title":"Von Willebrand disease and angiodysplasia responding to atorvastatin","volume":"142","author":"Sohal","year":"2008","journal-title":"Br J Haematol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109719305972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109719305972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:21:06Z","timestamp":1760016066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109719305972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":55,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0735109719305972"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2019.01.051","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735484034.793559306","asserted-by":"object"}]},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Angiotensin II Inhibitors on Gastrointestinal Bleeding in Patients With Left\u00a0Ventricular Assist Devices","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2019.01.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}